Skip to main content
Top
Published in: Calcified Tissue International 5/2023

20-09-2023 | Paget's Disease of Bone | Original Research

Genetic Screening of ZNF687 and PFN1 in a Paget’s Disease of Bone Cohort Indicates an Important Role for the Nuclear Localization Signal of ZNF687

Authors: Yentl Huybrechts, Raphaël De Ridder, Ellen Steenackers, Jean-Pierre Devogelaer, Geert Mortier, Gretl Hendrickx, Wim Van Hul

Published in: Calcified Tissue International | Issue 5/2023

Login to get access

Abstract

Paget’s disease of bone (PDB) is a common, late-onset bone disorder, characterized by focal increases of bone turnover that can result in bone lesions. Heterozygous pathogenic variants in the Sequestosome 1 (SQSTM1) gene are found to be the main genetic cause of PDB. More recently, PFN1 and ZNF687 have been identified as causal genes in patients with a severe, early-onset, polyostotic form of PDB, and an increased likelihood to develop giant cell tumors. In our study, we screened the coding regions of PFN1 and ZNF687 in a Belgian PDB cohort (n = 188). In the PFN1 gene, no variants could be identified, supporting the observation that variants in this gene are extremely rare in PDB. However, we identified 3 non-synonymous coding variants in ZNF687. Interestingly, two of these rare variants (p.Pro937His and p.Arg939Cys) were clustering in the nuclear localization signal of the encoded ZNF687 protein, also harboring the p.Pro937Arg variant, a previously reported disease-causing variant. In conclusion, our findings support the involvement of genetic variation in ZNF687 in the pathogenesis of classical PDB, thereby expanding its mutational spectrum.
Literature
17.
go back to reference Shirakawa J, Kajikawa S et al (2019) Profilin 1 negatively regulates osteoclast migration in postnatal skeletal growth, remodeling, and homeostasis in mice. JBMR Plus 3(6):e10130CrossRefPubMedPubMedCentral Shirakawa J, Kajikawa S et al (2019) Profilin 1 negatively regulates osteoclast migration in postnatal skeletal growth, remodeling, and homeostasis in mice. JBMR Plus 3(6):e10130CrossRefPubMedPubMedCentral
29.
go back to reference Huber CD, Kim BY et al (2020) Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution. Plos Genet 16(5):e1008827CrossRefPubMedPubMedCentral Huber CD, Kim BY et al (2020) Population genetic models of GERP scores suggest pervasive turnover of constrained sites across mammalian evolution. Plos Genet 16(5):e1008827CrossRefPubMedPubMedCentral
30.
Metadata
Title
Genetic Screening of ZNF687 and PFN1 in a Paget’s Disease of Bone Cohort Indicates an Important Role for the Nuclear Localization Signal of ZNF687
Authors
Yentl Huybrechts
Raphaël De Ridder
Ellen Steenackers
Jean-Pierre Devogelaer
Geert Mortier
Gretl Hendrickx
Wim Van Hul
Publication date
20-09-2023
Publisher
Springer US
Published in
Calcified Tissue International / Issue 5/2023
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-023-01137-5

Other articles of this Issue 5/2023

Calcified Tissue International 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine